There are over six million Americans with heart failure who are at greater risk of losing their cognitive abilities earlier in life, a study suggests. Global cognition and executive functioning declined more rapidly over the years after heart failure diagnosis, as people with the condition mentally aged the equivalent of 10 years within just seven years of a heart failure diagnosis.
Study led by Mount Sinai researcher could lead to more widespread use of imaging technique to improve survival and prevent complications
A new method of alerting clinical care providers holds promise for increasing treatment and improving survival for patients with severe aortic stenosis (AS), a valvular heart condition that can be deadly when left untreated. Researchers from UC San Francisco (UCSF) and Mass General Brigham found that electronic messages sent to providers within one week of patients receiving an echocardiogram improved care for patients with severe AS 鈥� including higher rates of treatment with aortic valve replacement (AVR), particularly in symptomatic patients.
South Africa鈥檚 2013 sodium reduction law is lowering blood pressure and improving health. A study by Wits & Harvard found a 10% drop in sodium intake, with stricter limits in processed foods. Even small reductions cut heart disease risk. Experts say more countries should follow suit. #PublicHealth
Trial led by Mount Sinai researcher could save lives for patients in need of urgent surgery, invasive procedures, or experiencing major bleeding
MiRus is pleased to announce the launch of the US multi-center Early Feasibility Study of the Siegel鈩� 8-Fr aortic transcatheter heart valve (THV).
Cause of Kawasaki disease has been elusive for over 50 years
Atrial fibrillation (AFib) is the most common type of heart arrhythmia impacting more than 5 million people in the United States, a number that is anticipated to reach 12.1 million by 2030. The heart rhythm condition is characterized by fast and irregular heartbeats from the upper chambers of the heart. People with AFib are at increased risk of stroke, heart failure, dementia, and premature death.
BACKGROUNDHeart disease remains a leading cause of mortality worldwide, with existing treatments often failing to effectively restore damaged myocardium. Human-induced pluripotent stem cells (hiPSCs) and their derivatives offer promising th
A scientific technique that rapidly increases the body鈥檚 production of anti-inflammatory cells promoted healing from heart attacks in mice, according to a new study by investigators from the Smidt Heart Institute at Cedars-Sinai.
Experts also available for interviews on trending topics and studies
Physicians and investigators from the Smidt Heart Institute at Cedars-Sinai will present research and be honored for their ongoing work in cardiovascular research and care during the American College of Cardiology鈥檚 Annual Scientific Session taking place March 29-31 in Chicago.
Ochsner Health Medical Director for Cardiac Rehabilitation and Preventive Cardiology, Carl J. 鈥淐hip鈥� Lavie, Jr., MD, recently co-authored a groundbreaking research study featured in the prestigious Mayo Clinic Proceedings highlighting the comparative efficacy of lipid-lowering therapies for reducing cardiovascular risks and led by Maciej Banach, MD,PhD from Poland and leader of the International Lipid Expert Panel ( ILEP).
A surprising mix of inherited and de novo mutations in 60 genes contribute to 10 percent of CHD cases. Many of these same mutations also contribute to neurodevelopmental disorders including autism.鈥�
A one of its kind study has uncovered the significant role that environmental pollution and healthcare disparities play in the prevalence of congenital heart defects in Mexico.
University Hospitals Harrington Heart & Vascular Institute at UH Portage Medical Center announces a significant reduction in cardiovascular mortality trends since a $2.5 million dollar investment to establish a local catheterization lab and preventive screening programs.
The Cardiovascular Research Foundation (CRF) is pleased to announce that registration is now open for TCT 2025 (Transcatheter Cardiovascular Therapeutics庐), the world鈥檚 premier educational symposium in interventional cardiovascular medicine. TCT 2025 will take place October 25-28, 2025, at the Moscone Center in San Francisco, California.
Researchers have shed new light on how a type of heart valve disease鈥攁ortic valve stenosis鈥攑rogresses differently in males and females. The research paves the way for treatments that can be tailored to a patient's biological sex.
Las enfermedades card铆acas son la principal causa de muerte en el mundo. Uno de los tipos m谩s comunes de enfermedades cardiovasculares es el infarto. Solo en Estados Unidos, se estima que cada 40 segundos, alguien sufre un infarto. Una de esas personas es el artista de m煤sica country-rap Colt Ford.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal 麻豆传媒 keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right